BioCentury | May 30, 2011
Company News

Vyteris supply/service news

...September to acquire CRO MediSync BioServices Inc. in a stock deal valued at $7.5 million. Vyteris...
...acquisition in April. Lidosite is a lidocaine HCl and epinephrine iontophoretic patch. At March 31, Vyteris...
...in cash and a three-month operating loss of $1.3 million (see BioCentury, Sept. 27, 2010). Vyteris Inc....
BioCentury | Sep 27, 2010
Company News

MediSync BioServices, Vyteris deal

...Drug delivery company Vyteris plans to acquire CRO MediSync in a stock deal valued at $7.5...
...deal was announced. MediSync stock and debt holders will receive 25 million new Vyteris shares. Vyteris...
...from MediSync will be appointed to Vyteris' board. MediSync BioServices Inc. , Delray Bay, Florida Vyteris Inc....
BioCentury | Aug 30, 2010
Company News

Vyteris, Georgia Institute of Technology deal

...The institute's tech transfer arm, Georgia Tech Research Corp., granted Vyteris an option for an exclusive...
...fabrication technology Vyteris could manufacture microstructures under mild conditions that do not harm encapsulated drugs. Vyteris...
...technologies. The university is eligible for milestones and royalties. Further financial terms were not disclosed. Vyteris Inc....
BioCentury | Feb 22, 2010
Company News

Vyteris board of directors update

Vyteris Inc. (OTCBB:VYTR), Fair Lawn, N.J. Business: Drug delivery Appointed: Eugene Bauer, president and CMO of Peplin Inc. , as chairman WIR Staff...
BioCentury | Feb 15, 2010
Financial News

Vyteris completes private placement of senior subordinated convertible notes

Vyteris Inc. (OTCBB:VYTR), Fair Lawn, N.J. Business: Drug delivery Date completed: 2/8/10 Type: Private placement of senior subordinated convertible notes Raised: $1.1 million Note: The notes bear no interest, mature in 2013 and convert at...
BioCentury | Apr 27, 2009
Company News

Vyteris, Zealand Pharma deal

...The partners will apply Vyteris' transdermal delivery technology to Zealand's peptide optimization technology to test the...
...the companies could decide to further develop and commercialize peptides incorporating the drug delivery technology. Vyteris Inc....
BioCentury | Jun 16, 2008
Company News

Vyteris Holdings Inc. drug delivery news

...As part of a restructuring announced in February, Vyteris is seeking to secure another peptide development...
...Patch coupled with an undisclosed peptide completed Phase I trials in female infertility this year. Vyteris...
...partner Ferring Pharmaceuticals A/S (Copenhagen, Denmark) to start Phase II trials of the transdermal patch. Vyteris...
BioCentury | May 19, 2008
Company News

Vyteris Holdings Inc. management update

Vyteris Holdings Inc. (OTCBB:VYHN), Fair Lawn, N.J. Business: Drug delivery Promoted: Haro Hartounian to president from chief technology officer; and Joseph Himy to CFO from VP of finance WIR Staff...
BioCentury | May 5, 2008
Company News

Vyteris Holdings Inc. board of directors update

Vyteris Holdings Inc. (OTCBB:VYHN), Fair Lawn, N.J. Business: Drug delivery Appointed: John Burrows, lead director of Technitrol Inc.; and Susan Guerin, SVP and CFO of Sun Chemical Corp. WIR Staff...
BioCentury | Apr 7, 2008
Finance

Restructuring watch

...Novo Nordisk (CSE:NVO; NYSE:NVO) to develop next-generation versions of Factors VIIa, VIII and IX 2/1/08 Vyteris...
Items per page:
1 - 10 of 21
BioCentury | May 30, 2011
Company News

Vyteris supply/service news

...September to acquire CRO MediSync BioServices Inc. in a stock deal valued at $7.5 million. Vyteris...
...acquisition in April. Lidosite is a lidocaine HCl and epinephrine iontophoretic patch. At March 31, Vyteris...
...in cash and a three-month operating loss of $1.3 million (see BioCentury, Sept. 27, 2010). Vyteris Inc....
BioCentury | Sep 27, 2010
Company News

MediSync BioServices, Vyteris deal

...Drug delivery company Vyteris plans to acquire CRO MediSync in a stock deal valued at $7.5...
...deal was announced. MediSync stock and debt holders will receive 25 million new Vyteris shares. Vyteris...
...from MediSync will be appointed to Vyteris' board. MediSync BioServices Inc. , Delray Bay, Florida Vyteris Inc....
BioCentury | Aug 30, 2010
Company News

Vyteris, Georgia Institute of Technology deal

...The institute's tech transfer arm, Georgia Tech Research Corp., granted Vyteris an option for an exclusive...
...fabrication technology Vyteris could manufacture microstructures under mild conditions that do not harm encapsulated drugs. Vyteris...
...technologies. The university is eligible for milestones and royalties. Further financial terms were not disclosed. Vyteris Inc....
BioCentury | Feb 22, 2010
Company News

Vyteris board of directors update

Vyteris Inc. (OTCBB:VYTR), Fair Lawn, N.J. Business: Drug delivery Appointed: Eugene Bauer, president and CMO of Peplin Inc. , as chairman WIR Staff...
BioCentury | Feb 15, 2010
Financial News

Vyteris completes private placement of senior subordinated convertible notes

Vyteris Inc. (OTCBB:VYTR), Fair Lawn, N.J. Business: Drug delivery Date completed: 2/8/10 Type: Private placement of senior subordinated convertible notes Raised: $1.1 million Note: The notes bear no interest, mature in 2013 and convert at...
BioCentury | Apr 27, 2009
Company News

Vyteris, Zealand Pharma deal

...The partners will apply Vyteris' transdermal delivery technology to Zealand's peptide optimization technology to test the...
...the companies could decide to further develop and commercialize peptides incorporating the drug delivery technology. Vyteris Inc....
BioCentury | Jun 16, 2008
Company News

Vyteris Holdings Inc. drug delivery news

...As part of a restructuring announced in February, Vyteris is seeking to secure another peptide development...
...Patch coupled with an undisclosed peptide completed Phase I trials in female infertility this year. Vyteris...
...partner Ferring Pharmaceuticals A/S (Copenhagen, Denmark) to start Phase II trials of the transdermal patch. Vyteris...
BioCentury | May 19, 2008
Company News

Vyteris Holdings Inc. management update

Vyteris Holdings Inc. (OTCBB:VYHN), Fair Lawn, N.J. Business: Drug delivery Promoted: Haro Hartounian to president from chief technology officer; and Joseph Himy to CFO from VP of finance WIR Staff...
BioCentury | May 5, 2008
Company News

Vyteris Holdings Inc. board of directors update

Vyteris Holdings Inc. (OTCBB:VYHN), Fair Lawn, N.J. Business: Drug delivery Appointed: John Burrows, lead director of Technitrol Inc.; and Susan Guerin, SVP and CFO of Sun Chemical Corp. WIR Staff...
BioCentury | Apr 7, 2008
Finance

Restructuring watch

...Novo Nordisk (CSE:NVO; NYSE:NVO) to develop next-generation versions of Factors VIIa, VIII and IX 2/1/08 Vyteris...
Items per page:
1 - 10 of 21